Protara Therapeutics, Inc.
TARANasdaqCIK 1359931HealthcareFiscal year ends Dec 31
Reports and events: 214 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1108:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-087508 |
| 2026-08-1108:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-087506 |
| 2026-06-2917:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-073184 |
| 2026-06-1516:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-068774 |
| 2026-05-1308:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-055463 |
| 2026-05-1308:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-055462 |
| 2026-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2026-06-12 | 0001213900-26-048536 |
| 2026-03-3008:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001213900-26-035971 |
| 2026-03-1008:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-025433 |
| 2026-03-1008:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-025432 |
| 2026-02-2408:52 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019617 |
| 2025-12-1516:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-121687 |
| 2025-12-0816:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-119242 |
| 2025-12-0308:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-117577 |
| 2025-11-1909:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112383 |
| 2025-11-1008:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-107881 |
| 2025-11-1008:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107873 |
| 2025-08-1108:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-073942 |
| 2025-08-1108:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-073937 |
| 2025-06-1216:17 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-053844 |
| 2025-05-0808:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-040811 |
| 2025-05-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-040809 |
| 2025-04-2808:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-035785 |
| 2025-04-2516:13 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001213900-25-035568 |
| 2025-03-0508:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-020368 |
| 2025-03-0508:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-020366 |
| 2025-01-1316:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-003026 |
| 2024-12-1116:19 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-107906 |
| 2024-12-0508:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-105782 |
| 2024-11-1208:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-096252 |
| 2024-11-1208:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-096243 |
| 2024-08-0608:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-065380 |
| 2024-08-0608:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-065378 |
| 2024-06-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-051210 |
| 2024-05-0208:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-038757 |
| 2024-05-0208:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-038756 |
| 2024-04-2616:05 ET | DEF 14A | Proxy statementPeriod 2024-06-07 | 0001213900-24-036627 |
| 2024-04-0508:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-030623 |
| 2024-03-1817:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-023589 |
| 2024-03-1308:10 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-021982 |
| 2024-03-1308:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-021981 |
| 2023-11-0308:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-083013 |
| 2023-11-0308:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-083011 |
| 2023-08-0308:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-062782 |
| 2023-08-0308:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-062780 |
| 2023-06-0816:06 ET | 8-K | 5.07 Shareholder vote results | 0001213900-23-047460 |
| 2023-05-0408:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-036113 |
| 2023-05-0408:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-036112 |
| 2023-05-0208:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-035154 |
| 2023-04-2808:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-033507 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.